BDNF and depressive symptom measurement: The possible underlying mechanisms may partly involve a reduction in oxidative stress and an elevation of BDNF, which in turn enhances functional neuron density in the prefrontal cortex, leading to an improvement in monoaminergic function that results in the alleviation of anxiety and depression.